Acumen Pharmaceuticals, Inc. ($ABOS)
Filing Information
| Accession Number | 0001628280-26-043987 |
|---|---|
| Form Type | 4 |
| Filing Date | Jun 17, 2026 |
| Document | View SEC Filing |
Transactions
7
Total Shares
71,300
Total Value
$96,104.50
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Jun 15, 2026 | Exercise/Conversion | 6,460 | $1.07 | $6,912.20 | 54,760 | Direct | โ | View Details | |
Director | Common Stock | โ | Jun 15, 2026 | Sale | 6,460 | $2.35 | $15,148.70 | 48,300 | Direct | โ | View Details | |
Director | Common Stock | โ | Jun 16, 2026 | Sale | 12,800 | $2.33 | $29,772.80 | 35,500 | Direct | โ | View Details | |
Director | Common Stock | โ | Jun 17, 2026 | Exercise/Conversion | 13,040 | $1.07 | $13,952.80 | 48,540 | Direct | โ | View Details | |
Director | Common Stock | โ | Jun 17, 2026 | Sale | 13,040 | $2.33 | $30,318.00 | 35,500 | Direct | โ | View Details | |
Director | Stock Option (right to buy) | Derivative | Jun 15, 2026 | Exercise/Conversion | 6,460 | $0.00 | $0.00 | 13,040 | Direct | โ | View Details | |
Director | Stock Option (right to buy) | Derivative | Jun 17, 2026 | Exercise/Conversion | 13,040 | $0.00 | $0.00 | 0 | Direct | โ | View Details |